Publications by authors named "Matthew Correa"

Claim this Profile
C
Correction to "Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005".
Patrick Papa, Brandon Whitefield, Deborah S Mortensen, Dan Cashion, Dehua Huang, Matthew Correa

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation".
Stephen Norris, Xiaochu Ba, Jayce Rhodes, Dehua Huang, Gody Khambatta, Matthew Correa

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation.
Stephen Norris, Xiaochu Ba, Jayce Rhodes, Dehua Huang, Gody Khambatta, Matthew Correa

J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.
Patrick Papa, Brandon Whitefield, Deborah S Mortensen, Dan Cashion, Dehua Huang, Matthew Correa

J Med Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia.
Joshua D Hansen, Matthew Correa, Matt Alexander, Mark Nagy, Dehua Huang

J Med Chem· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma.
Joshua D Hansen, Matthew Correa, Mark A Nagy, Matt Alexander, Veronique Plantevin

J Med Chem· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Degradation via CRL4 Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1.
Joshua D Hansen, Kevin Condroski, Matthew Correa, George Muller, Hon-Wah Man

J Med Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223.
Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, Jingjing Zhao, Garrick Packard, Matthew Correa

J Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115.
Deborah S Mortensen, Sophie M Perrin-Ninkovic, Graziella Shevlin, Jan Elsner, Jingjing Zhao, Matthew Correa

J Med Chem· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GTP binds to α-crystallin and causes a significant conformational change.
Jose A Mendoza, Matthew D Correa, Gustavo Zardeneta

Int J Biol Macromol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upper body cooling during exercise-heat stress wearing the improved toxicological agent protective system for HAZMAT operations.
Bruce S Cadarette, Leslie Levine, Janet E Staab, Margaret A Kolka, Matthew M Correa

AIHA J (Fairfax, Va)· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis